CIRM Board Approves Third Clinical Trial for COVID-19

Dr. Xiaokui Zhang (left), Dr. Albert Wong (center), and Dr. Preet Chaudhary (right) Today the governing Board of the California Institute for Regenerative Medicine (CIRM) awarded $750,000 to Dr. Xiaokui Zhang at Celularity to conduct a clinical trial for the treatment of COVID-19.  This brings the total number of CIRM clinical trials to 64, including … Continue reading CIRM Board Approves Third Clinical Trial for COVID-19

Stem Cell Agency Board Approves Three More Projects Targeting COVID-19

Dr. Jianhua Yu (left), Dr. Helen Blau (center), and Dr. Albert Wong (right) COVID‑19 targets many parts of the body, often with serious or life‑threatening effects. This past Friday, the CIRM Board approved investments in three early‑stage research projects that take new approaches to treating the virus. City of Hope Dr. Jianhua Yu at the … Continue reading Stem Cell Agency Board Approves Three More Projects Targeting COVID-19